FindTrial
Sign In

The retrospective cohort studies of postoperative adverse outcome in patients with SARS-CoV-2 infection

The retrospective cohort studies of postoperative adverse outcome in patients with SARS-CoV-2 infection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070579
Enrollment
Unknown
Registered
2023-04-17
Start date
2023-04-20
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sugery

Interventions

Control group:None
Covid-19 group:None

Sponsors

The Second Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients were operated in the Second Xiangya Hospital from October 1,2022 to March 1,2023

Exclusion criteria

Exclusion criteria: (1) Patients who did not undergo COVID-19 nucleic acid testing during hospitalization; (2) Day surgery patients; (2) Pregnant patients; (3) Patients with severe liver and kidney failure before surgery.

Design outcomes

Primary

MeasureTime frame
mortality;Length of hospital stay;postoperative complications;routine blood test;—

Secondary

MeasureTime frame
Liver and renal function tests;C-reactive protein;procalcitonin, PCT;—

Countries

China

Contacts

Public ContactRuping Dai

The Second Xiangya Hospital, Central South University

xyeyyrupingdai@csu.edu.cn+86 18974924753

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026